
Congress trades
Baxter International Inc. (BAX)
NYSE · Healthcare · 360 insider transactions · 124 congress trades · last filed 2 months agoS&P 500
About Baxter International Inc.
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Andrew Hider
- Employees
- 37,500
- Listed since
- Oct 27, 1981
- Market value
- $13.1B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$2.06
- Dividend yield
- 0.16%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $0.56 | $0.37 | $3.0B | $2.8B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $0.36 | $0.31 | $2.7B | $2.6B | EPS beatRevenue beat |
| Q4 FY2025reported Feb 12, 2026 | $0.44 | $0.53 | $3.0B | $2.8B | EPS missRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $0.69 | $0.60 | $2.8B | $2.8B | EPS beatRevenue in line |
| Q2 FY2025reported Jul 31, 2025 | $0.59 | $0.60 | $2.8B | $2.9B | EPS missRevenue miss |
| Q1 FY2025reported May 1, 2025 | $0.55 | $0.48 | $2.6B | $2.6B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Mar 23, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Reazur RasulExecutive Vice President and Group President, Healthcare Systems & Technologies | $800K | $3.0M | $1.5M | $5.2M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 3 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $1.7B | 81,842,105 | +3.1% | 15.83% |
| Pzena Investment Management LLC | $1.4B | 65,295,393 | +1.2% | 12.63% |
| Dodge & Cox | $1.2B | 58,386,345 | +2.0% | 11.29% |
| FMR LLC | $1.1B | 53,913,831 | +16.5% | 10.43% |
| Vanguard Capital Management LLC | $719.6M | 33,754,280 | +0.7% | 6.53% |
| Vanguard Portfolio Management LLC | $512.9M | 24,057,190 | +0.3% | 4.65% |
| State Street Corp | $439.4M | 20,600,468 | +3.1% | 4.00% |
| Greenhaven Associates Inc | $304.6M | 14,285,228 | -0.2% | 2.76% |
| Geode Capital Management, LLC | $300.6M | 14,123,689 | +2.6% | 2.73% |
| Invesco Ltd. | $263.6M | 12,361,881 | -5.8% | 2.39% |
| UBS Group AG | $203.2M | 9,529,309 | +120.6% | 1.84% |
| First Pacific Advisors, LP | $162.4M | 7,618,145 | +13.7% | 1.47% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Julie FosterPresident, Front Line Care | Tax withholding | 2,098 | Sep 2, 2026 |
| Andrew P. HiderPresident and CEO | Tax withholding | 54,276 | Sep 2, 2026 |
| James TeaffPresident, CCS | Tax withholding | 750 | Sep 1, 2026 |
| William A. Ampofo IIDirector | Stock award | 12,836 | May 5, 2026 |
| Jeffrey A. CraigDirector | Stock award | 12,836 | May 5, 2026 |
| Michael R. McDonnellDirector | Stock award | 12,836 | May 5, 2026 |
| David Brent ShaferDirector | Stock award | 12,836 | May 5, 2026 |
| Patricia MorrisonDirector | Stock award | 12,836 | May 5, 2026 |
| Nancy M. SchlichtingDirector | Stock award | 12,836 | May 5, 2026 |
| Amy McBride WendellDirector | Stock award | 12,836 | May 5, 2026 |
| David S. WilkesDirector | Stock award | 12,836 | May 5, 2026 |
| James TeaffPresident, CCS | Other Form 4 entry (see filing) | 55,119 | Apr 1, 2026 |
| Steven P. WallacePresident, Adv. Surgery | Other Form 4 entry (see filing) | 67,972 | Apr 1, 2026 |
| Julie FosterPresident, Front Line Care | Other Form 4 entry (see filing) | 25,862 | Apr 1, 2026 |
| Joel T. GradeEVP and CFO | Tax withholding | 8,153 | Mar 6, 2026 |
| Reazur RasulEVP, Group Pres, Healthcare | Tax withholding | 12,674 | Mar 6, 2026 |
| David S. RosenbloomEVP and General Counsel | Tax withholding | 6,620 | Mar 6, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Tax withholding | 2,848 | Mar 6, 2026 |
| Anita A. ZielinskiSVP, CAO and Controller | Tax withholding | 1,932 | Mar 6, 2026 |
| Anita A. ZielinskiSVP, CAO and Controller | Stock award | 30,864 | Feb 27, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in BAX
20 disclosures of 124 on record · median 24d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +47.0% since the tradeEstimated entry price $17.21, close on Fri May 1Current price $25.30, close on Fri Oct 23 | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +46.2% since the tradeEstimated entry price $17.30, close on Fri May 15Current price $25.30, close on Fri Oct 23 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +30.9% since the tradeEstimated entry price $19.33, close on Wed May 27Current price $25.30, close on Fri Oct 23 | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +39.3% since the saleEstimated exit price $18.16, close on Fri Apr 24Current price $25.30, close on Fri Oct 23 | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +43.5% since the saleEstimated exit price $17.63, close on Mon Apr 13Current price $25.30, close on Fri Oct 23 | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +60.1% since the saleEstimated exit price $15.80, close on Mon Mar 30Current price $25.30, close on Fri Oct 23 | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | +22.0% since the tradeEstimated entry price $20.74, close on Tue Feb 17Current price $25.30, close on Fri Oct 23 | Feb 17, 2026 | Mar 10, 2026 | 21d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.0% since the tradeEstimated entry price $20.74, close on Tue Feb 17Current price $25.30, close on Fri Oct 23 | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +28.8% since the tradeEstimated entry price $19.65, close on Tue Jan 13Current price $25.30, close on Fri Oct 23 | Jan 13, 2026 | Feb 11, 2026 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +28.2% since the tradeEstimated entry price $19.73, close on Thu Jan 29Current price $25.30, close on Fri Oct 23 | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +42.5% since the saleEstimated exit price $17.75, close on Mon Nov 10, 2025Current price $25.30, close on Fri Oct 23 | Nov 10, 2025 | Dec 8, 2025 | 28d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +32.0% since the tradeEstimated entry price $19.16, close on Thu Oct 30, 2025Current price $25.30, close on Fri Oct 23 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +32.0% since the saleEstimated exit price $19.16, close on Thu Oct 30, 2025Current price $25.30, close on Fri Oct 23 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +37.0% since the saleEstimated exit price $18.47, close on Fri Oct 31, 2025Current price $25.30, close on Fri Oct 23 | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +16.5% since the tradeEstimated entry price $21.71, close on Thu Sep 25, 2025Current price $25.30, close on Fri Oct 23 | Sep 25, 2025 | Oct 22, 2025 | 27d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +7.5% since the saleEstimated exit price $23.54, close on Wed Sep 3, 2025Current price $25.30, close on Fri Oct 23 | Sep 3, 2025 | Oct 3, 2025 | 30d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +3.6% since the saleEstimated exit price $24.42, close on Fri Sep 5, 2025Current price $25.30, close on Fri Oct 23 | Sep 5, 2025 | Oct 3, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.0% since the tradeEstimated entry price $22.38, close on Mon Sep 29, 2025Current price $25.30, close on Fri Oct 23 | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +12.7% since the saleEstimated exit price $22.44, close on Mon Aug 4, 2025Current price $25.30, close on Fri Oct 23 | Aug 4, 2025 | Sep 12, 2025 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +12.7% since the tradeEstimated entry price $22.44, close on Mon Aug 4, 2025Current price $25.30, close on Fri Oct 23 | Aug 4, 2025 | Sep 9, 2025 | 36d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in BAX, filterable by party, chamber, type and account.
Members of Congress reporting a position
3 members · estimate, as of Oct 24, 20263 members report a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Lucy McBath | Democrat · House | $1,001 - $15,000 | 0.2% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
| Debbie Wasserman Schultz | Democrat · House | $1,001 - $15,000 | 22.6% |
Estimate, as of Oct 24, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded BAX?
Ro Khanna, Michael T. McCaul and Lisa C. McClain disclosed BAX transactions in the filings shown here.
Which members of Congress hold BAX?
3 members of Congress report a position in BAX in the estimate we hold as of Oct 24, 2026. The estimated positions belong to Lucy McBath, Robert Bresnahan and Debbie Wasserman Schultz. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is BAX in the S&P 500 or the Nasdaq 100?
Baxter International Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 27, 2026. Current members of either index get a page here whatever their filing history.
How quickly are BAX trades disclosed?
Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.
